Histone deacetylase 2–mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Glucocorticoids are the most effective antiinflammatory agents for the treatment of chronic inflammatory diseases even though some diseases, such as chronic obstructive pulmonary disease (COPD), are relatively glucocorticoid insensitive. However, the molecular mechanism of this glucocorticoid insensitivity remains uncertain. We show that a defect of glucocorticoid receptor (GR) deacetylation caused by impaired histone deacetylase (HDAC) 2 induces glucocorticoid insensitivity toward nuclear factor (NF)-kappaB-mediated gene expression. Specific knockdown of HDAC2 by RNA interference resulted in reduced sensitivity to dexamethasone suppression of interleukin 1beta-induced granulocyte/macrophage colony-stimulating factor production. Loss of HDAC2 did not reduce GR nuclear translocation, GR binding to glucocorticoid response element (GRE) on DNA, or GR-induced DNA or gene induction but inhibited the association between GR and NF-kappaB. GR becomes acetylated after ligand binding, and HDAC2-mediated GR deacetylation enables GR binding to the NF-kappaB complex. Site-directed mutagenesis of K494 and K495 reduced GR acetylation, and the ability to repress NF-kappaB-dependent gene expression becomes insensitive to histone deacetylase inhibition. In conclusion, we show that overexpression of HDAC2 in glucocorticoid-insensitive alveolar macrophages from patients with COPD is able to restore glucocorticoid sensitivity. Thus, reduction of HDAC2 plays a critical role in glucocorticoid insensitivity in repressing NF-kappaB-mediated, but not GRE-mediated, gene expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent studies have shown that acetylation of GR by clock transcription factor reduces GR transcriptional activity82, 83.”
From Corticosteroids (2016) · cites this paper as [82]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Histone deacetylases (HDACs): characterization of the classical HDAC family
RUIJTER, A. J. M. D., GENNIP, A. H. V., CARON, H. N., KEMP, S., & KUILENBURG, A. B. P. V. (2003) · Biochemical Journal · doi:10.1042/bj20021321 · Cited by 3,114
Decreased Histone Deacetylase Activity in Chronic Obstructive Pulmonary Disease
Ito, K., Ito, M., Elliott, W. M., Cosio, B., Caramori, G., Kon, O. M., Barczyk, A., Hayashi, S., Adcock, I. M., Hogg, J. C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041892 · Cited by 968 · cited 2×
“In previous studies, we have found that total nuclear HDAC activity and HDAC2 expression are decreased in lung macrophages and peripheral lung tissue obtained from chronic obstructive pulmonary disease (COPD) (6, 7) and that the reduction correlates with disease severity.”
BackgroundSelf-citationIto, K., Barnes, P. J., & Adcock, I. M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.18.6891-6903.2000 · Cited by 723 · cited 7×
“A similar result was seen after treatment with TSA (19).”
BackgroundMethodResultInfluentialSelf-citationHistone Deacetylases: Unique Players in Shaping the Epigenetic Histone Code
THIAGALINGAM, S., CHENG, K., LEE, H. J., MINEVA, N., THIAGALINGAM, A., & PONTE, J. F. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb05964.x · Cited by 700 · cited 1×
“At least 18 HDACs are now recognized in mammalian cells (4, 5) and are grouped into 4 classes based on similarity of genes in yeast.”
BackgroundMolecular determinants of crosstalk between nuclear receptors and toll-like receptors
Ogawa, S., Lozach, J., Benner, C., Pascual, G., Tangirala, R. K., Westin, S., Hoffmann, A., Subramaniam, S., David, M., Rosenfeld, M. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.06.029 · Cited by 647 · cited 1×
“also show that the GR represses a large set of functionally related infl ammatory response genes by disrupting p65–interferon regulatory factor complexes (12).”
BackgroundNissen, R. M., & Yamamoto, K. R. (2000) · Genes & Development · doi:10.1101/gad.827900 · Cited by 559 · cited 1×
“1 C) and suggests that, at these supraphysiological concentrations, alternative mechanisms of action may be occurring (20).”
BackgroundITO, K., LIM, S., CARAMORI, G., CHUNG, K. F., BARNES, P. J., & ADCOCK, I. M. (2001) · The FASEB Journal · doi:10.1096/fj.00-0432fje · Cited by 481 · cited 3×
“In addition, there is a negative correlation between the repressive eff ect of Dex on cytokine production and total HDAC activity in alveolar macrophages from smokers and nonsmokers (16).”
BackgroundSelf-citationTheophylline Restores Histone Deacetylase Activity and Steroid Responses in COPD Macrophages
Cosio, B. G., Tsaprouni, L., Ito, K., Jazrawi, E., Adcock, I. M., & Barnes, P. J. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040416 · Cited by 473 · cited 2×
“In previous studies, we have found that total nuclear HDAC activity and HDAC2 expression are decreased in lung macrophages and peripheral lung tissue obtained from chronic obstructive pulmonary disease (COPD) (6, 7) and that the reduction correlates with disease severity.”
BackgroundSelf-citationLasa, M., Abraham, S. M., Boucheron, C., Saklatvala, J., & Clark, A. R. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.22.7802-7811.2002 · Cited by 382 · cited 1×
“Within the nucleus, GR either induces transcription of genes, such as secretary leukocyte proteinase inhibitor (SLPI) (8) and mitogen-activated kinase phosphatase–1 (9), or inhibits expression of genes such as IL-6 (10) by binding to specifi c DNA elements (glucocorticoid response elements [GREs]) at the promoter/enha…”
BackgroundWang, C., Fu, M., Angeletti, R. H., Siconolfi-Baez, L., Reutens, A. T., Albanese, C., Lisanti, M. P., Katzenellenbogen, B. S., Kato, S., Hopp, T., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100800200 · Cited by 366 · cited 1×
“GR is an acetylated protein and deacetylated by HDAC2 Previous studies have shown that both estrogen receptor α and androgen receptor are acetylated within their hinge/ ligand binding domains and that this can modulate hormoneinduced gene induction (21, 22).”
Background
Cited by
Items 101–200 of 646
The role of histone deacetylases in asthma and allergic diseases
Bhavsar, P. K., Ahmad, T., & Adcock, I. M. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.12.1156 · Cited by 131
Self-citationInhaled Corticosteroids in COPD: A Controversy
Barnes, P. J. (2010) · Respiration · doi:10.1159/000315416 · Cited by 143
Self-citationAirway epithelial barrier function regulates the pathogenesis of allergic asthma
Heijink, I. H., Nawijn, M. C., & Hackett, T. (2014) · Clinical & Experimental Allergy · doi:10.1111/cea.12296 · Cited by 137
Chung, K. F., Caramori, G., & Adcock, I. M. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0682-z · Cited by 147
“The steroid resistance of COPD observed in lung macrophages is completely reversed by overexpressing HDAC2 to the level seen in control subjects [96].”
BackgroundSelf-citationWhy do some asthma patients respond poorly to glucocorticoid therapy?
Henderson, I. L., Caiazzo, E., McSharry, C. P., Guzik, T. J., & Maffia, P. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105189 · Cited by 139
Histone deacetylase-2 and airway disease
Barnes, P. J. (2009) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465809348648 · Cited by 127
“and HDAC2 can target acetylated GR thereby allowing it to associate with the NF-kB complex [Ito et al. 2006] (Figure 1).”
BackgroundInfluentialSelf-citationEpigenetic effects of natural polyphenols: A focus on SIRT1‐mediated mechanisms
Ayissi, V. B. O., Ebrahimi, A., & Schluesenner, H. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300195 · Cited by 126
Glucocorticoids in the regulation of transcription factors that control cytokine synthesis
Liberman, A. C., Druker, J., Perone, M. J., & ARZT, E. S. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.01.005 · Cited by 148
“Therefore, HDAC2 regulates NF-kB-mediated inflammatory gene expression but does not affect GR transactivation activity [90].”
BackgroundBiochemical Basis of Asthma Therapy
Barnes, P. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.206466 · Cited by 136
Self-citationTranscription Factor NF-κB: An Update on Intervention Strategies
Panday, A., Inda, M. E., Bagam, P., Sahoo, M. K., Osorio, D., & Batra, S. (2016) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-016-0405-y · Cited by 123
“to corticosteroid resistance and oxidative stress, respectively, during emphysema (Ito et al. 2006) (Fig.”
BackgroundDifferential patterns of histone acetylation in inflammatory bowel diseases
Tsaprouni, L., Ito, K., Powell, J. J., Adcock, I. M., & Punchard, N. A. (2011) · Journal of Inflammation · doi:10.1186/1476-9255-8-1 · Cited by 132
“Modulation of histone acetylation is involved in transcriptional regulation, associated with the NF- B pathway [32-34].”
BackgroundSelf-citationGiembycz, M. A., Kaur, M., Leigh, R., & Newton, R. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707627 · Cited by 135
Newton, R., Leigh, R., & Giembycz, M. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.11.003 · Cited by 132
“In addition, deacetylation of the GR is suggested to promote interaction with p65, which provides an elegant mechanism by which transrepression could be targeted to NF-κB-containing promoters (Ito et al., 2006b).”
Emerging Pharmacotherapies for COPD
Barnes, P. J. (2008) · CHEST Journal · doi:10.1378/chest.08-1385 · Cited by 130
Self-citationSteelant, B., Wawrzyniak, P., Martens, K., Jonckheere, A., Pugin, B., Schrijvers, R., Bullens, D. M. A., Vanoirbeek, J., Krawczyk, K. T., Dreher, A., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.04.027 · Cited by 123
Barnes, P. J. (2010) · Pharmaceuticals · doi:10.3390/ph3030725 · Cited by 117
Self-citationMartinez, G. J., Appleton, M., Kipp, Z. A., Loria, A. S., Min, B., & Hinds, T. D. (2023) · Physiological Reviews · doi:10.1152/physrev.00021.2023 · Cited by 118
Watts, A. M., Cripps, A. W., West, N. P., & Cox, A. J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00294 · Cited by 121
“Deacetylation of core histones selectively attenuates the activity of NF-κB and AP-1, via tightening of the chromatin structure and reducing access of these transcription factors to their binding sites, thereby preventing the transcription of pro-inflammatory genes (Ito et al., 2006; Barnes, 2011).”
BackgroundWang, Y., Tian, Y., Morley, M. P., Lu, M. M., DeMayo, F. J., Olson, E. N., & Morrisey, E. E. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.01.012 · Cited by 110
“…with chronic obstructive pulmonary disease (COPD), a broad disease spectrum that leads to the irreversible loss of airway and alveolar structure and function and is thought to be due to a chronically defective injury-regeneration cycle caused by environmental insults (Ito et al., 2005, 2006).”
Passive Smoking Impairs Histone Deacetylase-2 in Children With Severe Asthma
Kobayashi, Y., Bossley, C., Gupta, A., Akashi, K., Tsartsali, L., Mercado, N., Barnes, P. J., Bush, A., & Ito, K. (2014) · Chest · doi:10.1378/chest.13-0835 · Cited by 109
Self-citationYao, H., & Rahman, I. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00175.2012 · Cited by 114
Chung, K. F., & Marwick, J. A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05600.x · Cited by 113
Kim, D. S., Kwon, J.-E., Lee, S. H., Kim, E. K., Ryu, J.-G., Jung, K.-A., Choi, J.-W., Park, M.-J., Moon, Y.-M., Park, S.-H., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01525 · Cited by 110
Modulation of Steroid Hormone Receptor Activity
Stanišić, V., Lonard, D. M., & O’Malley, B. W. (2010) · Progress in brain research · doi:10.1016/s0079-6123(08)81009-6 · Cited by 118
Majdalawieh, A. F., & Ro, J. (2010) · Mediators of Inflammation · doi:10.1155/2010/823821 · Cited by 124
“Interestingly, GR itself is subject to deacetylation by HDAC2, which leads to GR nuclear translocation and physical interaction with NF-κB subunits [247].”
BackgroundTruffault, F., de Montpréville, V., Eymard, B., Sharshar, T., Panse, R. L., & Berrih‐Aknin, S. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8558-3 · Cited by 113
Oxidative stress induced lung cancer and COPD: opportunities for epigenetic therapy
Lawless, M. W., O'Byrne, K. J., & Gray, S. G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00845.x · Cited by 113
“Critically as a consequence, loss of GR acetylation induces glucocorticoid insensitivity towards NF B-mediated gene expression [144], and restoration of HDAC2 by overexpression in glucocorticoid-insensitive alveolar macrophages from patients with COPD is able to restore glucocorticoid sensitivity [144].”
BackgroundMarwick, J. A., Caramori, G., Casolari, P., Mazzoni, F., Kirkham, P., Adcock, I. M., Chung, K. F., & Papi, A. A. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.02.003 · Cited by 115
Self-citationCOPD: a multifactorial systemic disease
Huertas, A., & Palange, P. (2011) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465811400490 · Cited by 118
“Overexpression or knockdown of HDAC2 in alveolar macrophages from COPD patients affects not only the inflammatory response but also corticosteroid responsiveness, suggesting an additional role for HDAC2 in the anti-inflammatory actions of the corticosteroid [Ito et al. 2006].”
BackgroundGene Expression Control by Glucocorticoid Receptors during Innate Immune Responses
Xavier, A. M., Anunciato, A. K. O., Rosenstock, T. R., & Glezer, I. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00031 · Cited by 118
“The acetylated GR is deacetylated by histone deacetylase 2 (HDAC2), and this deacetylation is necessary for the GR to be able to inhibit NF-κB activation (36).”
BackgroundLi, L.-B., Leung, D. Y. M., Martin, R. J., & Goleva, E. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0015oc · Cited by 99
Vlahos, R., Bozinovski, S., Hamilton, J. A., & Anderson, G. P. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.03.007 · Cited by 112
Posttranslational modifications of histone deacetylases: Implications for cardiovascular diseases
Eom, G. H., & Kook, H. Y. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.012 · Cited by 105
Tobacco use in relation to COPD and asthma: Fig. 1—
Hylkema, M. N., Sterk, P. J., de Boer, W. I., & Postma, D. S. (2007) · European Respiratory Journal · doi:10.1183/09031936.00124506 · Cited by 116
Antipsychotic-induced Hdac2 transcription via NF-κB leads to synaptic and cognitive side effects
Ibi, D., Revenga, M. D. L. F., Kezunovic, N., Muguruza, C., Saunders, J. M., Gaitonde, S. A., Moreno, J. L., Ijaz, M. K., Santosh, V., Kozlenkov, A., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4616 · Cited by 109
How inhaled corticosteroids target inflammation in COPD
Lea, S., Higham, A., Beech, A. S., & Singh, D. (2023) · European Respiratory Review · doi:10.1183/16000617.0084-2023 · Cited by 99
Steroid resistance in asthma: Mechanisms and treatment options
Adcock, I. M., Ford, P. A., Bhavsar, P. K., Ahmad, T., & Chung, K. F. (2008) · Current Allergy and Asthma Reports · doi:10.1007/s11882-008-0028-4 · Cited by 99
Self-citationPathak, S., Goldofsky, E., Vivas, E. X., Bonagura, V. R., & Vambutas, A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002275 · Cited by 98
Kang, S.-H., Seok, Y. M., Song, M.-J., Lee, H., Kurz, T., & Kim, I. (2015) · Molecular Pharmacology · doi:10.1124/mol.114.096974 · Cited by 99
“In the present study, MR interacted with HDAC1 and HDAC2 regardless of Aldo exposure (Supplemental Fig.”
Backgroundlan, N., Luo, G., Yang, X., Cheng, Y., Zhang, Y., Wang, X., Wang, X., Xie, T., Li, G., Liu, Z., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111599 · Cited by 102
“Glucocorticoid receptor (GR) nuclear translocation play a critical role in glucocorticoid therapy [25].”
BackgroundBosscher, K. D., Craenenbroeck, K. V., Meijer, O. C., & Haegeman, G. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.076 · Cited by 106
Lung Endoderm Morphogenesis: Gasping for Form and Function
Swarr, D. T., & Morrisey, E. E. (2015) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100814-125249 · Cited by 102
“Altered histone acetylation has been observed in association with several disease states in humans, including COPD and asthma, and in animal models of hyperoxic lung injury (Banerjee et al. 2012; Ito et al. 2002, 2006; Londhe et al. 2011; Zhu et al. 2012).”
BackgroundJeong, Y., Du, R., Zhu, X., Yin, S., Wang, J., Cui, H., Cao, W., & Lowenstein, C. J. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1013565 · Cited by 101
Current concepts in glucocorticoid resistance
Yang, N., Ray, D. W., & Matthews, L. C. (2012) · Steroids · doi:10.1016/j.steroids.2012.05.007 · Cited by 105
Yao, H., Sundar, I. K., Huang, Y., Gerloff, J., Sellix, M. T., Sime, P. J., & Rahman, I. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0474oc · Cited by 94
King, E. M., Chivers, J. E., Rider, C. F., Minnich, A., Giembycz, M. A., & Newton, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053936 · Cited by 102
Mitchell, M. C., Friedman, L. S., & McClain, C. J. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.08.047 · Cited by 93
Gatla, H. R., Muniraj, N., Thevkar, P., Yavvari, S., Sukhavasi, S., & Makena, M. R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051110 · Cited by 100
“In addition, Zhou et al. showed that CX3CL1 expression is controlled by HDACs and NF-κB in epithelial cells.”
BackgroundInfluentialNewton, R., Shah, S., Altonsy, M. O., & Gerber, A. N. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.777318 · Cited by 91
“Commonly referred to as transrepression, this dampens transcriptional activity at targeted promoters and may involve GR SUMOylation along with nuclear receptor co-repressors and histone deacetylase (HDAC) recruitment (20, 21).”
BackgroundBarnes, P. J. (2006) · Thorax · doi:10.1136/thx.2006.061002 · Cited by 88
Self-citationEpigenetic targets for novel therapies of lung diseases
Comer, B. S., Ba, M. A., Singer, C. A., & Gerthoffer, W. T. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.006 · Cited by 92
“The reduction in histone deacetylase activity correlated with decreases in HDAC1 and HDAC2 protein abundance, but no difference in histone acetyltransferase protein abundance was observed.”
InfluentialNortriptyline Reverses Corticosteroid Insensitivity by Inhibition of Phosphoinositide-3-Kinase-δ
Mercado, N., To, Y., Ito, K., & Barnes, P. J. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.175950 · Cited by 90
“…via inhibition of nuclear factor- B-associated histone acetylation by both direct inhibitions of CREB-binding protein-associated histone acetyltransferase activity and recruitment of histone deacetylase 2 (HDAC2) to the promoter of actively transcribed inflammatory genes (Ito et al., 2006a).”
BackgroundSelf-citationPeroxynitrite Elevation in Exhaled Breath Condensate of COPD and Its Inhibition by Fudosteine
Osoata, G. O., Hanazawa, T., Brindicci, C., Ito, M., Barnes, P. J., Ito, K., & Ito, K. (2009) · CHEST Journal · doi:10.1378/chest.08-2105 · Cited by 86
Self-citationRajendrasozhan, S., Yao, H., & Rahman, I. (2009) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550903049132 · Cited by 91
“It has also been shown that HDAC2 can deacetylate glucocorticoid receptor (GR) and hence increasing the association of GR with corepressor complex and subsequently attenuating the release of pro-inflammatory mediators (39).”
BackgroundLi, L., Bao, H., Wu, J., Duan, X., Liu, B., Sun, J., Gong, W., Lv, Y., Zhang, H., Luo, Q., et al. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.03.001 · Cited by 86
Nie, Y., Wu, H., Li, P., Luo, Y.-L., Zhang, C., Shen, J., & Su, W. (2012) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2012.06.004 · Cited by 85
Athira, K. V., Madhana, R. M., Indu Chandran, J. S., Lahkar, M., Sinha, S., & Naidu, V. G. M. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.02.009 · Cited by 90
“GCs can interact with other transcription factors, such as NF-κB, in which HDAC2 is reported to play a prominent role [66].”
BackgroundTrans-regulation of Histone Deacetylase Activities through Acetylation
Luo, Y., Jian, W., Stavreva, D., Fu, X., Hager, G., Bungert, J., Huang, S., & Qiu, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.038356 · Cited by 78
Grabiec, A. M., Tak, P. P., & Reedquist, K. A. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2489 · Cited by 90
Shao, D., Perros, F., Caramori, G., Meng, C., Dormuller, P., Chou, P.-C., Church, C., Papi, A. A., Casolari, P., Welsh, D., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.06.111 · Cited by 83
“The relative expression of target genes was quantified using the DDCt method normalised to housekeeping genes (b-actin or GAPDH) as described previously [7,28].”
MethodSelf-citationOxidative Stress Promotes Corticosteroid Insensitivity in Asthma and COPD
Lewis, B. W., Ford, M. L., Rogers, L. K., & Britt, R. D. (2021) · Antioxidants · doi:10.3390/antiox10091335 · Cited by 87
Eom, G. H., Nam, Y. S., Oh, J. G., Choe, N., Min, H.-K., Yoo, E.-K., Kang, G., Nguyen, V. H., Min, J.-J., Kim, J.-K., et al. (2014) · Circulation Research · doi:10.1161/circresaha.114.303429 · Cited by 81
Knobloch, J., Sibbing, B., Jungck, D., Lin, Y., Urban, K., Stoelben, E., Strauch, J., & Koch, A. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.166843 · Cited by 89
The etiologic origins for chronic obstructive pulmonary disease
Huang, X., Xi, M., Deng, L., Fu, A., Pu, E., Tang, T., & Kong, X. (2019) · International Journal of COPD · doi:10.2147/copd.s203215 · Cited by 93
Sevilla, L. M., Jiménez‐Panizo, A., Alegre‐Martí, A., Estébanez‐Perpiñá, E., Caelles, C., & Pérez, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810049 · Cited by 85
“Also, resistance to GCs in COPD patients can be mediated by a defect in GR deacetylation due to decreased HDAC2 expression in alveolar macrophages, which specifically inhibits NF-κB transpression by hormone-bound GR [77].”
BackgroundInhibition of Histone Deacetylases in Inflammatory Bowel Diseases
Glauben, R., & Siegmund, B. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00069 · Cited by 77
“In addition, HDAC2 was required for glucocorticoid-induced suppression of inflammatory mediator production from human alveolar macrophages (47).”
BackgroundRole of histone acetylation in cell physiology and diseases: An update
Khan, S. N., & Khan, A. U. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.06.020 · Cited by 95
Treating COPD with PDE 4 inhibitors.
Brown, W. M. (2007) · PubMed Central · Cited by 78
New Therapies for Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2010) · Medical Principles and Practice · doi:10.1159/000316368 · Cited by 87
“This results in increased acetylation of the glucocorticoid receptor which prevents it from inhibiting NF-κB-driven inflammation [”
BackgroundSelf-citationImmunopathogenesis of chronic obstructive pulmonary disease
Holloway, R. A., & Donnelly, L. (2013) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32835cfff5 · Cited by 85
“In COPD, HDAC2 expression is decreased and is negatively correlated with disease severity [27], but when overexpressed in COPD cells there is restoration of glucocorticosteroid sensitivity [28].”
BackgroundDominance of the strongest: Inflammatory cytokines versus glucocorticoids
Dejager, L., Vandevyver, S., Πέττα, Ι., & Libert, C. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.12.006 · Cited by 85
“drugs against kinases, such as p38 and JNK MAPK [23].”
BackgroundInfluentialHepatic Osteodystrophy—Molecular Mechanisms Proposed to Favor Its Development
Ehnert, S., Aspera-Werz, R. H., Ruoß, M., Dooley, S., Hengstler, J. G., Nadalin, S., Relja, B., Badke, A., & Nussler, A. K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102555 · Cited by 72
Hoffmann, R. F., Jonker, M. R., Brandenburg, S. M., de Bruin, H. G., ten Hacken, N. H. T., van Oosterhout, A. J. M., & Heijink, I. H. (2019) · Scientific Reports · doi:10.1038/s41598-019-51517-x · Cited by 84
Sionov, R. V., Spokoini, R., Kfir‐Erenfeld, S., Cohen, O., & Yefenof, E. (2008) · Advances in cancer research · doi:10.1016/s0065-230x(08)00406-5 · Cited by 88
“Selective suppression of HDAC2, but not HDAC1 or HDAC3, reduced sensitivity to Dex suppression of IL‐1 ‐induced GM‐CSF production (Ito et al., 2006).”
BackgroundInfluentialImpact of protein acetylation in inflammatory lung diseases
Ito, K., Charron, C. E., & Adcock, I. M. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.009 · Cited by 81
Self-citationKino, T., & Chrousos, G. P. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.12.001 · Cited by 74
“Deacetylation of GR by this HDAC was required for efficient transrepression of nuclear factor of κ B (NF-κ B)-induced transcriptional activity by the GR (Ito et al., 2006).”
BackgroundMethodRossios, C., To, Y., To, M., Ito, M., Barnes, P. J., Adcock, I. M., Johnson, M. W., & Ito, K. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.08.022 · Cited by 76
Self-citationGlucocorticoid therapy and ocular hypertension
Dibas, A., & Yorio, T. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.06.018 · Cited by 75
“The same study reported that deacetylation of the GRα by HDAC2 was necessary for binding of the receptor to NF-κB and repression of downstream target genes.”
BackgroundAdenuga, D., & Rahman, I. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.04.002 · Cited by 76
Histone deacetylases in viral infections
Herbein, G., & Wendling, D. (2010) · Clinical Epigenetics · doi:10.1007/s13148-010-0003-5 · Cited by 82
“HDAC2 deacetylates the glucocorticoid receptor and HDAC3 is needed for the deacetylation of myocyte enhancer factor-2 (MEF-2) (Gregoire et al. 2007; Ito et al. 2006).”
BackgroundAberrant histone modification in peripheral blood B cells from patients with systemic sclerosis
Wang, Y., Yang, Y., Luo, Y., Yin, Y., Wang, Q., Li, Y., Kanekura, T., Wang, J., Liang, G., Zhao, M., et al. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.06.006 · Cited by 73
Marwick, J. A., Ito, K., Adcock, I. M., & Kirkham, P. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.6.745 · Cited by 82
“The authors have recently reported that GR is acetylated on ligand binding and that deacetylation of GR is essential for GR-p65 association although GR-GRE binding is not affected by changes in GR acetylation status [64].”
BackgroundMethodInfluentialSelf-citationEpigenetics and the developmental origins of lung disease
Joss‐Moore, L. A., Albertine, K. H., & Lane, R. H. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.07.018 · Cited by 74
Acetylation and nuclear receptor action
Wang, C., Tian, L., Popov, V. M., & Pestell, R. G. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.12.003 · Cited by 76
Corticosteroid resistance in asthma: Cellular and molecular mechanisms
Caramori, G., Nucera, F., Mumby, S. E., Bello, F. L., & Adcock, I. M. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.100969 · Cited by 73
Self-citationRecovery of neutrophil apoptosis by ectoine: a new strategy against lung inflammation
Sydlik, U., Peuschel, H., Paunel‐Görgülü, A., Keymel, S., Krämer, U., Weissenberg, A., Kroker, M., Seghrouchni, S., Heiß, C., Windolf, J., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00132211 · Cited by 72
“Neutrophils in general do not respond well to anti-inflammatory therapies like corticosteroid treatment (6) and, in the case of COPD, may even become resistant to this kind of therapy (7).”
BackgroundMurugan, V., & Peck, M. J. (2009) · Experimental Lung Research · doi:10.1080/01902140902759290 · Cited by 70
“from healthy control subjects by over expression of HDAC2 protein [57].”
BackgroundResultGeroprotectors as a novel therapeutic strategy for COPD, an accelerating aging disease
Ito, K., Colley, J. R., & Mercado, N. (2012) · International Journal of COPD · doi:10.2147/copd.s28250 · Cited by 73
Self-citationGlucocorticoid receptor β and histone deacetylase 1 and 2 expression in the airways of severe asthma
Butler, C. A., McQuaid, S., Taggart, C. C., Weldon, S., Carter, R., Skibiński, G., Warke, T. J., Choy, D. F., McGarvey, L. P., Bradding, P., et al. (2011) · Thorax · doi:10.1136/thoraxjnl-2011-200760 · Cited by 77
“Proposed molecular mechanisms for glucocorticoid resistance include abnormalities of glucocorticoid binding, reduced glucocorticoid receptor nuclear translocation in response to steroids,(5) 6 increased expression of pro-inflammatory transcription factors (eg, activator protein-1 and nuclear factor-kB)(7) 8 and altere…”
BackgroundMechanisms of glucocorticoid action and insensitivity in airways disease
Boardman, C., Chachi, L., Gavrila, A., Keenan, C. R., Perry, M. M., Xia, Y., Meurs, H., & Sharma, P. K. (2014) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2014.08.008 · Cited by 82
“The glucocorticoid resistance of bronchoalveolar macrophages from individuals with COPD can be reversed by overexpressing HDAC2 to the level seen in healthy individuals [164].”
BackgroundChana, K. K., Fenwick, P. S., Nicholson, A. G., Barnes, P. J., & Donnelly, L. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.08.044 · Cited by 72
Self-citationFrank, F., Liu, X., & Ortlund, E. A. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2024685118 · Cited by 68
Mercado, N., To, Y., Kobayashi, Y., Adcock, I. M., Barnes, P. J., & Ito, K. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.071993 · Cited by 71
“1128 activator protein-1 and nuclear factor- B (NF- B), or by recruitment of corepressors such as histone deacetylase 2 (Ito et al., 2006a,b).”
BackgroundSelf-citationCorticosteroid insensitivity is reversed by formoterol via phosphoinositide‐3‐kinase inhibition
Rossios, C., To, Y., Osoata, G. O., Ito, M., Barnes, P. J., & Ito, K. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01864.x · Cited by 68
“The IL-8 production is less sensitive to corticosteroids (Ito et al., 2006; Armstrong et al., 2009), and we demonstrated that TNF-a-induced IL-8 production in peripheral blood mononuclear cells (PBMCs) is a good marker for evaluating corticosteroid sensitivity (To et al.”
BackgroundSelf-citationNuclear receptors in inflammation control: Repression by GR and beyond
Chinenov, Y., Gupte, R., & Rogatsky, I. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.04.006 · Cited by 61
“Furthermore, HDAC2 depletion both inhibited GR deacetylation and also prevented GR:p65 interaction without affecting GR DNA binding (Ito et al. 2006).”
Transcriptional Regulation of Endothelial Arginase 2 by Histone Deacetylase 2
Pandey, D., Sikka, G., Bergman, Y., Kim, J. H., Ryoo, S., Romer, L., & Berkowitz, D. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.303685 · Cited by 64
Epigenome-Modifying Tools in Asthma
Brook, P., Perry, M. M., Adcock, I. M., & Durham, A. L. (2015) · Epigenomics · doi:10.2217/epi.15.53 · Cited by 70
Self-citationGlucocorticoid Receptor Signaling in Diabetes
Kokkinopoulou, I., Diakoumi, A., & Moutsatsou, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011173 · Cited by 70
“In addition, GR regulates the expression and activity of many genes involved in these metabolic processes via heterodimerization with other transcription factors including AP-1, NF-κB, and STAT-5 [54–56].”
BackgroundInfluentialO papel do estresse oxidativo na DPOC: conceitos atuais e perspectivas
Cavalcante, A. G. D. M., & de Bruin, P. F. C. (2009) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132009001200011 · Cited by 92
Impact of post-translational modifications of proteins on the inflammatory process
Ito, K. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350281 · Cited by 61
Self-citation
Metadata
- Authors
- Ito, K., Yamamura, S., Essilfie-Quaye, S., Cosio, B., Ito, M., Barnes, P. J., & Adcock, I. M.
- Affiliations
- Imperial College London (GB)
- Airway Disease Section, National Heart and Lung Institute, Imperial College, London SW3 6LY, England, UK
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2005-12-27
- Volume
- 203
- Issue
- 1
- Pages
- 7-13
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2118081
- OpenAlex
- W2131160124
- Cited by
- 638
- References
- 28
- Citations by year
- 2026: 20 · 2025: 12 · 2024: 9 · 2023: 16 · 2022: 14 · 2021: 28 · 2020: 21 · 2019: 31 · 2018: 18 · 2017: 29 · 2016: 36 · 2015: 36 · 2014: 45 · 2013: 50 · 2012: 39
- FWCI
- 11.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- GlaxoSmithKline
- European Respiratory Society
- British Lung Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- HDAC2, glucocorticoid receptor, glucocorticoid resistance, NF-κB, chronic obstructive pulmonary disease, alveolar macrophages, dexamethasone, IL-1β, GM-CSF, glucocorticoid response element, transcriptional repression
- MeSH terms
- Cells, Cultured, Dexamethasone, Histone Deacetylases, Humans, Interleukin-1, Receptors, Glucocorticoid, Repressor Proteins, Transfection, Transcriptional Activation, Gene Expression Regulation, Enzymologic, Granulocyte-Macrophage Colony-Stimulating Factor, NF-kappa B, Macrophages, Alveolar, Pulmonary Disease, Chronic Obstructive, RNA, Small Interfering, Cell Line, Tumor, Histone Deacetylase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.